Research and Markets, the largest resource for market research information in world providing essential market research reports, industry research, industry analysis, forecasts, market studies, company profiles and country reports.
Welcome - Register - Login - Help/FAQ - 0 items View Basket
Worlds Largest Market Research Resource - 1516232 Live Reports
Search Research and Markets
  Search
Enter keywords, a title or
a report id number below.





Advanced   
Company search
Register for free email updates of market research
Currency
  Select a currency for use throughout the site



Viewing report

Order by Fax
Ask a Question
Printer Friendly
PDF Brochure
Hard CopyAdd to Basket
Live Chat Live Help Software for Website

Ganciclovir Therapy for Cytomegalovirus Infection

Informa Healthcare, June 1991, Pages: 270


  Description  
    
    
    
    
     
  Enquire before Buying   
  Send to a Friend   

Ganciclovir (formerly DHPG) is the first drug to show any effectiveness against diseases caused by cytomegalovirus, which include congenital infection, and conditions almost invariably fatal to organ recipients and patients with AIDS. Reviews the preclinical and clinical studies on the drug's pharma



Customers who bought this item also bought

Competitor Analysis: Cytomegalovirus (CMV) Vaccines and Therapeutics

Cytomegalovirus Infection Therapy Area Pipeline Report

Future Infectious Disease Nucleic Acid Testing

Emerging Blood Typing, Grouping and Infectious Disease Screening Tests and Companies Developing New Technologies

Emerging Transfusion Diagnostic Tests and Companies Developing Innovative Technologies and Products

Emerging Microbiology Tests and Companies Developing New Technologies and Products

Blood Typing, Grouping and Infectious Disease Screening Tests: Emerging Assays and Companies Developing New Technologies and Products

Viral Hepatitis

Mucocutaneous Manifestations of Viral Diseases: An Illustrated Guide to Diagnosis and Management, Second Edition

Global Nosocomial Infection Drug Pipeline Capsule - 2012
For enquiries please call us on:
  +353-1-415-1241 (GMT Office Hours)
  1-800-526-8630 (US/Canada Toll Free)
  1-917-300-0470 (EST Office Hours)

   All rights reserved. © Copyright 2012 Research and Markets
   Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network


Research and Markets RSS Feeds